FDA Inspection 1122166 — Evonik Operations GmbH
The FDA completed an inspection of Evonik Operations GmbH on Feb 18, 2020 in Marl. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 18, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Marl (Germany)